Locally Advanced or Metastatic Solid Tumors Clinical Trial
Official title:
Phase I Dose Escalation and Dose Expansion, International, Multicenter Study of W0180 as Single Agent and in Combination With Pembrolizumab (Anti-PD-1) in Adult Participants With Locally Advanced or Metastatic Solid Tumors
The purpose of this study will be to determine the Maximum Tolerated Dose (MTD) and describe dose-limiting toxicities (DLTs) of W0180 given as monotherapy and in combination with pembrolizumab (anti-PD-1).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04511845 -
A Dose-Escalation Study of SPYK04 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).
|
Phase 1 | |
| Active, not recruiting |
NCT04128423 -
Study of AMV564 in Subjects With Advanced Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT05012618 -
A Dose-escalation Study of LUNA18 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).
|
Phase 1 | |
| Recruiting |
NCT05581004 -
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
|
Phase 1 | |
| Completed |
NCT03736850 -
Study of CS3006 in Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT05137275 -
Study of Anti-5T4 CAR-raNK Cell Therapy in Locally Advanced or Metastatic Solid Tumors
|
Early Phase 1 | |
| Completed |
NCT01021748 -
A Combination Therapy Study of MK-2206 and AZD6244 in Participants With Advanced Solid Tumors (MK-2206-010)
|
Phase 1 | |
| Completed |
NCT01713036 -
Oral Bioavailability and Mass Balance Trial With Pimasertib
|
Phase 1 | |
| Recruiting |
NCT05116709 -
Assessment of Safety and Preliminary Clinical Efficacy With BAT6005 in Advanced Malignant Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT05102214 -
HLX301 (TIGIT×PDL1 Bispecific) in Patients With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT03478995 -
Study to Evaluate Safety and Tolerability of GX-I7 in Patients With Locally Advanced or Metastatic Solid Tumors
|
Phase 1 | |
| Not yet recruiting |
NCT06293651 -
Clinical Trial to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DA-4505 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06328439 -
A Study to Evaluate ANS014004 in Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1 | |
| Active, not recruiting |
NCT05830539 -
IN10018 Combination Therapy in Previously-treated Locally Advanced or Metastatic Solid Tumor Patients
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05205109 -
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of ATG 037 Monotherapy and Combination Therapy With Pembrolizumab in Patients With Advanced Solid Tumors
|
Phase 1 | |
| Active, not recruiting |
NCT05360381 -
HLX35(EGFR×4-1BB Bispecific) in Patients With Advanced or Metastatic Solid Tumors
|
Phase 1 | |
| Completed |
NCT03150810 -
Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05957471 -
Study of BC3195 Monotherapy in Patients With Advanced Solid Tumors
|
Phase 1 | |
| Terminated |
NCT03565991 -
Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors
|
Phase 2 | |
| Recruiting |
NCT06244992 -
PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 |